Institute of Biomedical Chemistry (IBMC), Laboratory of Mass Spectrometric Metabolomic Diagnostics
Title: Associate Researcher
Jan 2020 - Oct 2022 (2 yrs 10 mos)
Employment type: Part-time
en.ibmc.msk.ru →
Jan 2020 - Oct 2022 (2 yrs 10 mos)
Employment type: Part-time
en.ibmc.msk.ru →
Outline: The main work of the laboratory is related to metabolomic studies of body fluids to characterize the functioning of a biological object in a pathological state, as well as the development of diagnostic methods based on metabolites – low-molecular (up to 1500 Da) organic compounds that are substrates, intermediates, or products of biochemical reactions
Institute of Biomedical Chemistry (IBMC), Laboratory of Mass Spectrometric Metabolomic Diagnostics
Title: Associate Researcher
Jan 2020 - Oct 2022 (2 yrs 10 mos)
Employment type: Part-time
en.ibmc.msk.ru →
Jan 2020 - Oct 2022 (2 yrs 10 mos)
Employment type: Part-time
en.ibmc.msk.ru →
Outline: The main work of the laboratory is related to metabolomic studies of body fluids to characterize the functioning of a biological object in a pathological state, as well as the development of diagnostic methods based on metabolites – low-molecular (up to 1500 Da) organic compounds that are substrates, intermediates, or products of biochemical reactions
Key Achievements
Key Achievements
- Authored and co-authored 9 scientific papers on Metabolomics in international
- Q1-level scientific journals
- Engaged in hands-on lab activities and performed experiments with human blood samples on “Bruker timsTOF” and “Bruker maXis Impact” mass spectrometers
- Developed the concept of global-scale application of Metabolomics, the world's first Metabolomic Laboratory-Developed Test (LDT), and declared it in the international journal Metabolites with an impact factor of 5.581
- Authored and co-authored 9 scientific papers on Metabolomics in international
- Q1-level scientific journals
- Engaged in hands-on lab activities and performed experiments with human blood samples on “Bruker timsTOF” and “Bruker maXis Impact” mass spectrometers
- Developed the concept of global-scale application of Metabolomics, the world's first Metabolomic Laboratory-Developed Test (LDT), and declared it in the international journal Metabolites with an impact factor of 5.581
Media
Explore more visual insights
Media
Explore more visual insights